Benefit-Risk Assessment Based on Number Needed to Treat and Number Needed to Harm: Atogepant vs Calcitonin Gene–Related Peptide Monoclonal Antibodies (P5-12.007)Simona Sacco, Anjana Lalla,Rashmi Halker Singh, Dagney Holle-Lee,Patricia Pozo-Rosich, Krisztian Nagy, Kari Kelton, Cristiano Piron,Pranav Gandhi,Jessica AilaniNeurology(2024)引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要